Skip to main navigation
Skip to search
Skip to main content
University of Kentucky Home
LOGIN & Help
Home
Research units
Researchers
Grants & Contracts
Research output
Facilities & Equipment
Honors & Awards
Activities
Search by expertise, name or affiliation
A Phase III Multicenter Open Label Long Term Study of the Safety Tolerablity and Efficacy of Intravenous Antegren (Natalizumab) in Chron's Disease Subjects Who Have Previously Participated in Studies CD251 CD301 CD303 or CD306 (ELN100226-CD351)
De Villiers, Willem
(PI)
Internal Medicine
Overview
Grants and Contracts Details
Status
Finished
Effective start/end date
2/1/03
→
2/1/07
View all
View less